Chemosensitisation of malignant melanoma by BCL2 antisense therapy. - Jansen,B.; Wacheck,V.; Heere-Ress,E.; Schlagbauer-Wadl,H.; Hoeller,C.; Lucas,T.; Hoermann,M.; Hollenstein,U.; Wolff,K.; Pehamberger,H. (Lancet, 2000)